Proven to reduce viral loading on products and surfaces, a new range of antiviral technologies is being introduced by Microban. The technology can be incorporated into various materials during manufacturing, becoming part of the product’s structure to provide inherent and enduring protection from microbes.
Recent data demonstrates that new antiviral technologies from Microban International Ltd., Huntersville, NC/USA, conform to both ISO 18184 – which assesses the antiviral performance of treated textile products, such as woven and knitted fabrics, fibers, yarns, and braids – and ISO 21702, which measures activity in treated plastics and other non-porous surfaces. Thorough testing was performed to evaluate the efficacy of each product type against many viruses, including bacteriophage Phi6, an important surrogate virus for SARS-CoV-2. The results showed that articles treated with these technologies can now benefit from reduced viral loading by up to 99 %.
Antiviral technologies from Microban inhibit the viruses’ ability to remain viable on surfaces. The modes of action vary, disrupting the structure of either the outer protein coat – to prevent viruses from recognizing or binding to host cells – or nucleic acid payload, to prevent viral replication.